Provided by Tiger Trade Technology Pte. Ltd.

Biomarin Pharmaceutical

54.89
-0.3100-0.56%
Post-market: 54.80-0.0900-0.16%19:30 EDT
Volume:3.10M
Turnover:169.55M
Market Cap:10.61B
PE:144.83
High:54.97
Open:54.95
Low:53.90
Close:55.20
52wk High:70.98
52wk Low:49.26
Shares:193.27M
Float Shares:192.12M
Volume Ratio:1.24
T/O Rate:1.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3790
EPS(LYR):1.80
ROE:1.18%
ROA:3.26%
PB:1.68
PE(LYR):30.49

Loading ...

Jan 12, 2024

Major Issues Report

Form 8-K - Current report
Jan 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 21, 2023

Major Issues Report

Form 8-K - Current report
Dec 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 04, 2023

Major Issues Report

Form 8-K - Current report
Nov 03, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2023

Major Issues Report

Form 8-K - Current report
Aug 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 10, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 09, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2023

Major Issues Report

Form 8-K - Current report
May 30, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities